CLINICAL ROLE -
Immune Checkpoint Inhibitors in Head and Neck Cancers Offer Different Treatment Approaches
Guidelines indicate that there are a number of treatment options for head and neck cancers.
Understanding the Evolving Landscape of Malignant Melanoma
This Continuing Education activity is supported by an educational grant from Merck Sharpe & Dohme Corp.
2 Clarke Drive Cranbury, NJ 08512